The 5-year cumulative risk was higher in subjects with symptomatic hemorrhage at presentation (33.3%), CCM2 genotype (33.3%), presence of at least one CCM in the brainstem at first brain MRI (26.7%), and positive family history (20.7%). Here, CCM2 is linked to hemorrhage.